CA2160251A1 - Use of ceruletide diethyl amine salt in the treatment of psoriasis - Google Patents
Use of ceruletide diethyl amine salt in the treatment of psoriasisInfo
- Publication number
- CA2160251A1 CA2160251A1 CA002160251A CA2160251A CA2160251A1 CA 2160251 A1 CA2160251 A1 CA 2160251A1 CA 002160251 A CA002160251 A CA 002160251A CA 2160251 A CA2160251 A CA 2160251A CA 2160251 A1 CA2160251 A1 CA 2160251A1
- Authority
- CA
- Canada
- Prior art keywords
- badges
- psoriasis
- ceruletide
- treatment
- amine salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2207—Gastrins; Cholecystokinins [CCK]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI940298A IT1274015B (it) | 1994-02-18 | 1994-02-18 | Uso del ceruletide (takus) nel trattamento della psoriasi |
| ITMI94A000298 | 1994-02-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2160251A1 true CA2160251A1 (en) | 1995-08-24 |
Family
ID=11367909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002160251A Abandoned CA2160251A1 (en) | 1994-02-18 | 1995-02-13 | Use of ceruletide diethyl amine salt in the treatment of psoriasis |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0696203A1 (it) |
| JP (1) | JPH08509245A (it) |
| AU (1) | AU2146595A (it) |
| CA (1) | CA2160251A1 (it) |
| FI (1) | FI954912L (it) |
| HU (1) | HU9503295D0 (it) |
| IL (1) | IL112578A0 (it) |
| IT (1) | IT1274015B (it) |
| MX (1) | MX9504335A (it) |
| NO (1) | NO954115L (it) |
| PL (1) | PL311159A1 (it) |
| WO (1) | WO1995022346A1 (it) |
| ZA (1) | ZA951137B (it) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3034531C2 (de) * | 1980-09-12 | 1986-09-18 | Farmitalia Carlo Erba S.p.A., Mailand/Milano | Verwendung von Polypeptiden als Analgetikum in der Human- und Tiermedizin |
| JPS6041052B2 (ja) * | 1981-04-07 | 1985-09-13 | 塩野義製薬株式会社 | 向精神薬 |
-
1994
- 1994-02-18 IT ITMI940298A patent/IT1274015B/it active IP Right Grant
-
1995
- 1995-02-08 IL IL11257895A patent/IL112578A0/xx unknown
- 1995-02-13 HU HU9503295A patent/HU9503295D0/hu unknown
- 1995-02-13 JP JP7521701A patent/JPH08509245A/ja active Pending
- 1995-02-13 FI FI954912A patent/FI954912L/fi not_active Application Discontinuation
- 1995-02-13 MX MX9504335A patent/MX9504335A/es unknown
- 1995-02-13 PL PL95311159A patent/PL311159A1/xx unknown
- 1995-02-13 CA CA002160251A patent/CA2160251A1/en not_active Abandoned
- 1995-02-13 EP EP95914489A patent/EP0696203A1/en not_active Withdrawn
- 1995-02-13 ZA ZA951137A patent/ZA951137B/xx unknown
- 1995-02-13 AU AU21465/95A patent/AU2146595A/en not_active Abandoned
- 1995-02-13 WO PCT/IB1995/000282 patent/WO1995022346A1/en not_active Ceased
- 1995-10-16 NO NO954115A patent/NO954115L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI954912A0 (fi) | 1995-10-16 |
| PL311159A1 (en) | 1996-02-05 |
| NO954115D0 (no) | 1995-10-16 |
| HU9503295D0 (en) | 1996-01-29 |
| FI954912A7 (fi) | 1995-10-16 |
| EP0696203A1 (en) | 1996-02-14 |
| NO954115L (no) | 1995-10-16 |
| ITMI940298A1 (it) | 1995-08-19 |
| MX9504335A (es) | 1997-05-31 |
| ITMI940298A0 (it) | 1994-02-18 |
| ZA951137B (en) | 1995-12-01 |
| AU2146595A (en) | 1995-09-04 |
| JPH08509245A (ja) | 1996-10-01 |
| IL112578A0 (en) | 1995-05-26 |
| IT1274015B (it) | 1997-07-14 |
| FI954912L (fi) | 1995-10-16 |
| WO1995022346A1 (en) | 1995-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bagnasco et al. | Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings | |
| Levine et al. | Reduction of feeding in rats by calcitonin | |
| Richardson | SIMMONDS'DISEASE AND ANOREXIA NERVOSA | |
| Biskind | Nutritional deficiency in the etiology of menorrhagia, metrorrhagia, cystic mastitis and premenstrual tension; treatment with vitamin B complex | |
| BR112020006246A2 (pt) | Método para controle do peso de um sujeito em necessidade | |
| Levai | A study of certain contributory factors in the development of vitiligo in South Indian patients | |
| Muss | Interferon therapy of metastatic renal cell cancer | |
| Gregoriadis et al. | HLA antigens and otosclerosis: a possible new genetic factor | |
| Taira et al. | Antioxidative effects of a novel dietary supplement Neumentix in a mouse stroke model | |
| Bobeica et al. | Immunologic and nonimmunologic sclerodermal skin conditions-review | |
| Salter et al. | The calorigenic action of thyroxin polypeptide | |
| CA2160251A1 (en) | Use of ceruletide diethyl amine salt in the treatment of psoriasis | |
| US11564958B2 (en) | Compositions and methods of treatment of Ehlers-Danlos syndromes | |
| Cope et al. | Effect of 9α-Fluorohydrocortisone on Adrenal Hyperfunction in Cushing's Syndrome | |
| Loew et al. | Effect of long-distance flights on oedema of the lower extremities | |
| VON | Blood pressure and estrogens | |
| CN101879151A (zh) | 大黄素在制备p2x3介导神经病理痛/神经系统疾病药物中的应用 | |
| Falta | endocrine diseases: including their diagnosis and treatment | |
| Reinehr et al. | Flagellate hyperpigmentation | |
| Smith | Tongue Changes in British Troops | |
| Jungkunz et al. | Acute effects of the synthetic analogue of methionine enkephalin FK 33-824 on depressive symptoms | |
| RU2119350C1 (ru) | Средство для лечения псориаза | |
| Ji et al. | Clinical characteristics of endocrine disturbances in post-COVID-19 condition, case report with review of literature | |
| RU1803115C (ru) | Средство дл лечени красного плоского лиша | |
| Ahmad et al. | Effect of dexamethasone on pituitary prolactin in the lizard Uromastix hardwickii |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |